During the past decade, Buffalo Heart Group conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 8 clinical trials were completed, i.e. on average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 4 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Buffalo Heart Group" #1 sponsor was "Abbott Medical Devices" with 3 trials, followed by "Bristol-Myers Squibb" with 2 trials sponsored, "Cerenis Therapeutics, SA" with 2 trials sponsored, "Pfizer" with 2 trials sponsored and "Biosite" with 2 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Buffalo Heart Group" #1 collaborator was "Baim Institute for Clinical Research" with 1 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator, "CTI Clinical Trial and Consulting Services" with 1 trials as a collaborator, "Daiichi Sankyo, Inc." with 1 trials as a collaborator and "Duke Clinical Research Institute" with 1 trials as a collaborator. Other collaborators include 2 different institutions and companies that were collaborators in the rest 12 trials.

According to Clinical.Site data, the most researched conditions in "Buffalo Heart Group" are "Cardiovascular Disease" (5 trials), "Coronary Artery Disease" (3 trials), "Acute Coronary Syndromes" (2 trials), "Acute Coronary Syndrome" (1 trials) and "Acute Coronary Syndrome (ACS)" (1 trials). Many other conditions were trialed in "Buffalo Heart Group" in a lesser frequency.

Most popular intervention types in "Buffalo Heart Group" are "Drug" (13 trials), "Device" (4 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "CER-001" (2 trials), "bococizumab (PF-04950615)" (2 trials), "Acetylsalicylic acid" (1 trials) and "Acetylsalicylic acid placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Buffalo Heart Group" are 17 trials for "All" genders.

Currently, there are NaN active trials in "Buffalo Heart Group". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in Buffalo Heart Group, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Buffalo Heart Group, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 1 trials that are defined as “Not Applicable".